Rett syndrome is an X-linked neurodevelopmental disorder that predominantly affects females. It is caused by mutations in methyl-CpG-binding protein 2 gene. Due to the sex-limited expression, it has been suggested that de novo X-linked mutations may exclusively occur in male germ cells and thus only females are affected. In this study, the authors have analyzed the parental origin of mutations and the X-chromosome inactivation status in 24 sporadic patients with identified methyl-CpG-binding protein2 gene mutations. The results showed that 22 of 24 patients have a paternal origin. Only 2 patients have a maternal origin. Except for 2 cases which were homozygotic at the androgen receptor gene locus, of the remaining 22 cases, 16 cases have a random X-chromosome inactivation pattern; the other 6 cases have a skewed X-chromosome inactivation and they favor expression of the wild allele. The relationship between X-chromosome inactivation and phenotype may need more cases to explore.
Amir RE, Van den Veyver IB, Wan M., Tran CQ, Francke U., Zoghbi HYRett syndrome is caused by mutation in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23(2):185-188.
2.
Li MR, Pan H., Bao XH, Zhang YZ, Wu XRMECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome . J Hum Genet. 2007;52(1):38-47.
3.
Amir RE, Van den Veyver IB, Schultz R., et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol. 2000 ;47(5):670-679.
4.
Wan M., Lee SS, Zhang X., et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet. 1999;65(6):1520-1529.
5.
Villard L., Kpebe A., Cardoso C., Chelly PJ, Tardieu PM, Fontes M.Two affected boys in a Rett syndrome family: clinical and molecular findings . Neurology. 2000;55(8):1188-1193.
6.
Meloni I., Bruttini M., Longo I., et al. A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet. 2000;67(4):982-985.
7.
Orrico A., Lam C., Galli L., et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 2000; 481(3):285-288.
8.
Dayer AG, Bottani A., Bouchardy I., et al. MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother. Brain Dev. 2007;29(1):47-50.
9.
Girard M., Couvert P., Carrié A., et al. Parental origin of de novo MECP2 mutations in Rett syndrome . Eur J Hum Genet. 2001; 9(3):231-236.
10.
Trappe R., Laccone F., Cobilanschi J., et al. MECP2 mutations in sporadic patients of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet. 2001;68(5):1093-1101.
11.
Archer H., Evans J., Leonard H., et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet. 2007;44(2): 148-152.
12.
Hagberg B., Hanefeld F., Percy A., Skjeldal O.An update on clinically applicable diagnostic criteria in Rett syndrome. Eur J Paediatr Neurol. 2002;6:293-297.
13.
Wu DY, Ugozzoli L., Pal BK, Wallace RBAllele-specific enzymatic amplification of β-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci U S A. 1989;86(8): 2757-2760.
14.
Newton CR, Graham A., Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory system (ARMS). Nucleic Acids Res. 1989;17(7):2503-2516.
15.
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JWMethylation of HpaII and HhaII sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992; 51(6):1229-1239.
16.
Pan H., Li MR, Nelson P., Bao XH, Wu XR, Yu S.Large deletions of the MECP2 gene in Chinese patients with classical Rett syndrome. Clin Genet. 2006;70(5):418-419.
17.
Kerr AM, Belichenko P., Woodcock T., Woodcock M.Mind and brain in Rett disorder. Brain Dev. 2001;23(suppl 1):S44-S49.
18.
Wettke-Schäfer R., Kantner G.X-linked dominant inherited diseases with lethality in hemizygous males. Hum Genet. 1983; 64(1):1-23.
19.
Budden SS, Dorsey HC, Steiner RDClinical profile of a male with Rett syndrome. Brain Dev. 2005;27(suppl 1):S69-S71.
20.
Maiwald R., Bönte A., Jung H., et al. De novo MECP2 mutation in a 46, XX male patient with Rett syndrome . Neurogenetics. 2002; 4(2):107-108.
21.
Masuyama T. , Matsuo M., Jing JJ, et al. Classic Rett syndrome in a boy with R133C mutation of MECP2. Brain Dev. 2005;27(6): 439-442.
22.
Thomas GHHigh male:female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders . Am J Hum Genet. 1996; 58(6):1364-1368.
23.
Evans JC, Archer HL, Whatley SD, Clarke A.Germline mosaicism for a MECP2 mutation in a man with two Rett daughters. Clin Genet. 2006;70(4):336-338.
24.
Goto T., Monk M.Regulation of X-chromosome inactivation in development in mice and humans . Microbiol Mol Biol Rev. 1998;62(2):362-378.
25.
Zoghbi HY, Percy AK, Schultz RJ, Fill C.Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev. 1990;12(1):131-135.
26.
LaSalle JM, Goldstine J., Balmer D., Greco CMQuantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet. 2001; 10(17):1729-1740.
27.
Shahbazian MD , Sun Y., Zoghbi HY. Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet. 2002;111(2):164-168.
28.
Gibson JH, Williamson SL, Arbuckle S., Christodoulou J.X chromosome inactivation patterns in brain in Rett syndrome: implications for the disease phenotype. Brain Dev. 2005 ;27(4): 266-270.
29.
Colvin L., Leonard H., de Klerk N., et al. Refining the phenotype of common mutations in Rett syndrome . J Med Genet. 2004;41(1):25-30.
30.
Xinhua Bao , Shengling Jiang, Fuying Song, Hong Pan , Meirong Li , Wu XRX chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype. J Child Neurol. 2008;23(1):22-25.
31.
Balmer D., Arredondo J., Samaco RC, LaSalle JMMECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet. 2002;110(6):545-552.
